)
United Therapeutics (UTHR) investor relations material
United Therapeutics UBS Global Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Financial and operational highlights
Achieved double-digit year-over-year growth in the Tyvaso franchise, driven by continued expansion in PH-ILD and strong adoption of both DPI and nebulizer formats.
Noted no material impact from new competitors, with market expansion attributed to increased awareness and diagnosis.
Expressed confidence in reaching a $4 billion revenue run rate by the end of 2027, supported by recent clinical trial clarity.
Higher-dose Tyvaso cartridges (80, 96, 112 mcg) to launch soon, enhancing patient convenience and supporting those on higher doses.
No active partnership discussions currently, but open to future collaborations to support global market expansion.
Clinical development and pipeline updates
TETON-2 trial for IPF delivered best-ever data for the indication, with strong efficacy and safety; TETON-1 results expected by mid-2026.
Discontinuation rates in TETON-2 were in line with previous IPF trials, with efficacy accumulating after titration to effective dose.
Ralinepag advanced outcomes trial is powered for six-minute walk distance and PVR endpoints, with data expected in the first half of 2026.
Ralinepag offers once-daily, titratable dosing, aiming for differentiation from competitors.
Xenotransplantation program
First clinical IND kidney transplant using a 10-gene edited organ completed, marking a major milestone.
Study structured in two cohorts: initial six patients, followed by a review and potential expansion to 44+ patients.
Next public update expected after completion of the first cohort; timelines remain uncertain due to study complexity.
Platform differentiation includes targeted gene edits and a long history of R&D investment; market size allows for multiple successful players.
Next United Therapeutics earnings date
Next United Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)